New Patient PricingLimited time: GLP-1 plans from $99/mo.Claim now

Your First Two Weeks on a GLP-1: What Is Normal?

LM

Written by Join Luma Team

November 8, 2026 · 8 min read

Calendar and notebook for tracking early treatment experiences

Quick answer

During your first two weeks on a GLP-1, appetite changes, early fullness, nausea, constipation or fatigue can occur, but some people notice little change.

Mild symptoms can often be discussed with your clinician; severe abdominal pain, persistent vomiting, dehydration or an allergic reaction require urgent medical attention.

What changes might I notice in the first few days?

You may become satisfied with a smaller meal, lose interest in snacks, or notice that food sits heavily if you eat your usual portion. Others feel much the same during the first weeks. The timing and intensity of appetite effects differ, so neither a dramatic response nor an uneventful first dose is required for treatment to be on track.

GLP-1 medicines influence appetite and delay stomach emptying. That can make eating past comfortable fullness unpleasant. Start with a smaller serving and leave yourself permission to have more if you remain hungry. Your early goal is learning your response while staying nourished, not seeing how little food you can tolerate. See what to expect from your first injection for preparation tips.

Why does treatment begin with a low dose?

The starting dose is a tolerability step: it introduces the medication gradually rather than trying to reach a maintenance dose immediately. The FDA-approved Wegovy and Zepbound labels use gradual dose escalation to reduce gastrointestinal reactions. Those brand schedules are references, not a personalized Join Luma schedule.

Stay with the dose on your prescription until your Join Luma clinician directs otherwise. Feeling hungry in week two is not permission to take an extra dose, and nausea is not a reason to design your own smaller dose. Tell the care team what you are experiencing so it can decide whether any adjustment is appropriate. The Zepbound prescribing information and Instructions for Use states:

“The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage.”

— Zepbound prescribing information and Instructions for Use, NLM DailyMed
Source: NLM DailyMed, Zepbound prescribing information and Instructions for Use

Which early symptoms can occur, and how should I respond?

Early adjustment versus reasons to escalate care
ExperienceUseful next step
Mild nausea or early fullnessTry smaller meals and record triggers; contact the clinician if persistent.
ConstipationReview fluid intake, gradually increase tolerated fiber and stay active.
FatigueCheck whether you are eating and drinking enough; report ongoing or marked fatigue.
Persistent vomiting or severe painSeek urgent care, not routine reassurance.

Nausea, vomiting, diarrhea, constipation and fatigue are reported in FDA-approved product labeling, but not everyone experiences them. Symptoms that are manageable initially can become a problem if they interfere with drinking, eating or daily activity. You do not need to wait until a scheduled follow-up to ask for help. The Wegovy prescribing information and Medication Guide describes gastrointestinal adverse reactions and dehydration-related kidney risk.

What should I eat when I feel full or nauseated?

Build modest meals around foods you can tolerate. Try a small serving of protein, a starch such as toast or rice, and fruit or vegetables as tolerated. Eat slowly, pause during the meal, and stop before uncomfortable fullness. Very rich meals, large portions and eating quickly may be less comfortable while you are adjusting.

  • Keep easy options available: yogurt if tolerated, eggs, soup, tofu, fish, beans or another familiar protein source.
  • Sip fluids through the day rather than trying to make up a long gap with a large drink at once. Follow any fluid restriction prescribed for another condition.
  • If smells trigger nausea, try cooler or simpler foods, and avoid lying down immediately after a large meal.
  • If nausea prevents normal intake or keeps recurring, contact Join Luma rather than adding medicines or supplements on your own.

The protein calculator can support meal planning, but a clinician or dietitian can tailor a target to your medical needs. The aim is consistent nutrition, not a rigid menu or forcing yourself to finish a large plate.

How can I manage constipation and low energy?

Smaller food intake and changes in routine can affect bowel habits. Increase fiber gradually rather than adding a large amount overnight, drink adequate fluids if medically appropriate, and keep moving with short walks or other comfortable activity. The Treatment for Constipation recommends fluids, fiber and activity as part of constipation treatment.

Ask your clinician before starting a laxative, especially if constipation is new, persistent or accompanied by pain. Severe abdominal pain, vomiting, a swollen abdomen or inability to pass gas needs prompt assessment rather than repeated home remedies. Track bowel movements so the care team can distinguish a mild change from a worsening pattern.

For fatigue, check practical basics: have you skipped several meals, slept poorly or cut fluids because of nausea? These are useful clues, not a diagnosis. Marked weakness, fainting or dehydration needs urgent care. Persistent tiredness deserves clinician review even if you suspect the medication is involved.

What should I record before the second weekly dose?

Keep a short log of dose time, injection site, appetite, meals, fluid intake, bowel movements and any symptoms. Write down severity and duration rather than just “felt bad.” For example, knowing whether nausea lasted an hour after dinner or prevented drinking all day changes the clinical conversation.

Avoid judging success from a single weigh-in. Fluid balance, constipation and ordinary day-to-day variation can obscure a trend. Check your prescription before the next dose, and use the missed-dose guide only as a brand-label reference if your schedule is disrupted. Join Luma support is available through the portal or support@joinluma.com for non-emergency questions.

Which symptoms need urgent medical attention?

Seek urgent care for severe or persistent abdominal pain, especially pain that spreads to your back, persistent vomiting, inability to keep fluids down, or signs of dehydration such as very little urine or marked dizziness. These are not symptoms to simply push through until your next appointment. Severe stomach pain can signal pancreatitis or another condition needing prompt assessment.

Call 911 for trouble breathing, swelling of the face, lips, tongue or throat, fainting, or other signs of a severe allergic reaction. Do not take another dose while a serious medication reaction is being assessed. If you use insulin or a sulfonylurea, ask your clinician about low blood sugar and follow your existing treatment plan for it. The Wegovy prescribing information and Medication Guide and Zepbound prescribing information and Instructions for Use describe these precautions.

Which instructions should Join Luma patients follow?

Your prescription label and Join Luma clinician’s directions take priority over general information about brand-name products. Compounded semaglutide and compounded tirzepatide are not FDA-approved. FDA-approved brand labels provide useful reference information, but their devices, concentrations, storage allowances and study results do not automatically apply to a compounded prescription.

The Understanding the Risks of Compounded Drugs explains this distinction. Keep the pharmacy label available when asking a question: it identifies the medication, concentration, directions and beyond-use date. A photograph of that label and the supplied syringe can help the care team resolve a measurement question without guessing. Never use someone else’s dose or syringe marking as your own instructions.

Same price every dose

Start your online visit

A licensed provider reviews your intake. If treatment is appropriate, your medication ships free with expedited two-day delivery.

Get started

Sources & further reading

  1. NLM DailyMed. Wegovy prescribing information and Medication Guide.
  2. NLM DailyMed. Zepbound prescribing information and Instructions for Use.
  3. National Institute of Diabetes and Digestive and Kidney Diseases. Treatment for Constipation.
  4. U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs.

Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality before marketing. Brand-product study results describe the FDA-approved products studied. A licensed clinician decides whether treatment is appropriate; follow your prescription label and your clinician's directions.

This article is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Individual treatment decisions should be made with a licensed healthcare provider.

More questions people ask

Is it normal to feel nothing after the first dose?

Some people notice little change during the first two weeks. Continue only the prescribed dose and discuss your response with your Join Luma clinician rather than increasing it yourself.

Does nausea mean I am losing more weight?

No. Nausea is a side effect, not a measure of treatment success, and you do not need to feel sick for treatment to help.

Can I skip meals because I am not hungry?

Regular, manageable meals can help maintain nutrition when appetite is reduced. If you cannot eat or drink adequately, contact your clinician; dehydration or persistent vomiting requires urgent care.

Will side effects definitely stop after two weeks?

There is no guaranteed two-week deadline. Tell your clinician about symptoms that persist, worsen or interfere with eating, drinking or daily life.

Should I increase my dose in week two?

Do not increase early unless your Join Luma clinician specifically directs it. Gradual initiation is intended to improve tolerability.

Medically reviewed by

Dr. Sean Arora, MD

Clinically reviewed and edited by Dr. Sean Arora, MD.

Share this article

Related articles